Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you

The Trump administration's mass cancellation of AHRQ research grants is threatening decades of bipartisan progress on patient safety. Former AHRQ leaders warn that halting studies on hospital infections, diagnostic errors, and AI-assisted care could cost lives. Medical errors are already estimated to be the third leading cause of death in the U.S. — and cutting the research that prevents them carries serious consequences.
The Agency for Healthcare Research and Quality (AHRQ) has long been the quiet engine behind some of America's biggest patient safety wins — from slashing hospital-acquired infections to improving care transitions and reducing diagnostic errors. But this summer, the Trump administration's sweeping cancellation of AHRQ research grants is putting that progress in jeopardy, according to two former AHRQ leaders who served under both Republican and Democratic administrations.
Writing in MedPage Today, former AHRQ director Carolyn Clancy and senior legislative leader Boyce Ginieczki argue that patient safety has never been — and should never become — a partisan issue. They point to real-world casualties of the cuts: a University of Pittsburgh study on safe ICU-to-home transitions and a University of Wisconsin project using AI to improve safety for hospitalized children were both abruptly terminated.
By the Numbers:
Why it matters: AHRQ's work doesn't just save lives — it reduces Medicare and Medicaid spending on avoidable harm. Dismantling this research infrastructure risks reversing hard-won gains in care quality at a time when the healthcare system is growing more complex, not less.